These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23165431)

  • 21. Association between Benign Prostatic Hyperplasia and Neutrophil-Lymphocyte Ratio, an Indicator of Inflammation and Metabolic Syndrome.
    Ozer K; Horsanali MO; Gorgel SN; Horsanali BO; Ozbek E
    Urol Int; 2017; 98(4):466-471. PubMed ID: 27464069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia.
    Cyrus A; Kabir A; Goodarzi D; Talaei A; Moradi A; Rafiee M; Moghimi M; Shahbazi E; Farmani E
    Korean J Urol; 2014 Dec; 55(12):814-20. PubMed ID: 25512816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.
    Gacci M; Corona G; Vignozzi L; Salvi M; Serni S; De Nunzio C; Tubaro A; Oelke M; Carini M; Maggi M
    BJU Int; 2015 Jan; 115(1):24-31. PubMed ID: 24602293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The independent association of non-alcoholic fatty liver disease with lower urinary tract symptoms/benign prostatic hyperplasia and erectile function scores.
    Eren H; Horsanali MO
    BJU Int; 2019 Aug; 124(2):329-335. PubMed ID: 30900792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study.
    Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Tubaro A; Vignozzi L; Corona G; McVary KT; Kaplan SA; Maggi M; Carini M; Serni S
    BJU Int; 2015 Aug; 116(2):271-7. PubMed ID: 25597623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is periurethral calcification associated with urinary flow rate and symptom severity in men with lower urinary tract symptoms-benign prostatic hyperplasia? A retrospective review.
    Han JH; Kwon JK; Lee JY; Kang DH; Choi HC; Lee JS; Cho KS
    Urology; 2015 May; 85(5):1156-1161. PubMed ID: 25818911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between lipid profile and heme oxygenase system in patients with benign prostatic hyperplasia.
    Vanella L; Russo GI; Cimino S; Fragalà E; Favilla V; Li Volti G; Barbagallo I; Sorrenti V; Morgia G
    Urology; 2014 Jun; 83(6):1444.e7-13. PubMed ID: 24862399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Relationship between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study.
    Fu Y; Zhou Z; Yang B; Zhang K; He L; Zhang X
    Urol Int; 2016; 97(3):330-335. PubMed ID: 27509202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
    Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
    Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
    Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
    BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the clinical value of a simple flowmeter in the management of male lower urinary tract symptoms.
    Chan CK; Yip SK; Wu IP; Li ML; Chan NH
    BJU Int; 2012 Jun; 109(11):1690-6. PubMed ID: 21933332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower urinary tract symptom improvement after radical prostatectomy correlates with degree of prostatic inflammation.
    Burris MB; Cathro HP; Kowalik CG; Jensen D; Culp SH; Steers WD; Krupski TL
    Urology; 2014 Jan; 83(1):186-90. PubMed ID: 24246320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Stief CG; Porst H; Neuser D; Beneke M; Ulbrich E
    Eur Urol; 2008 Jun; 53(6):1236-44. PubMed ID: 18281145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Men with Hypertension are More Likely to Have Severe Lower Urinary Tract Symptoms and Large Prostate Volume.
    Hwang EC; Kim SO; Nam DH; Yu HS; Hwang I; Jung SI; Kang TW; Kwon DD; Kim GS
    Low Urin Tract Symptoms; 2015 Jan; 7(1):32-6. PubMed ID: 26663649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.
    Ozden C; Ozdal OL; Urgancioglu G; Koyuncu H; Gokkaya S; Memis A
    Eur Urol; 2007 Jan; 51(1):199-203; discussion 204-6. PubMed ID: 16806666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of estimated glomerular filtration rate with lower urinary tract symptoms/benign prostatic hyperplasia measures in middle-aged men with moderate to severe lower urinary tract symptoms.
    Lee JH; Kwon H; Park YW; Cho IC; Min SK
    Urology; 2013 Dec; 82(6):1381-5. PubMed ID: 24063940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms.
    Lee RK; Chung D; Chughtai B; Te AE; Kaplan SA
    BJU Int; 2012 Aug; 110(4):540-5. PubMed ID: 22243806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between Metabolic Syndrome and Predictors for Clinical Benign Prostatic Hyperplasia Progression and International Prostate Symptom Score in Patients with Moderate to Severe Lower Urinary Tract Symptoms.
    Zhao S; Chen C; Chen Z; Xia M; Tang J; Shao S; Yan Y
    Urol J; 2016 Jun; 13(3):2717-26. PubMed ID: 27351328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower urinary tract symptoms in benign prostatic hyperplasia patients: orchestrated by chronic prostatic inflammation and prostatic calculi?
    Kim SH; Jung KI; Koh JS; Min KO; Cho SY; Kim HW
    Urol Int; 2013; 90(2):144-9. PubMed ID: 23295780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.
    Vignozzi L; Gacci M; Maggi M
    Nat Rev Urol; 2016 Feb; 13(2):108-19. PubMed ID: 26754190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.